Chaparala, A.; Poudyal, D.; Witalison, E.E.; Tashkandi, H.; Chumanevich, A.A.; Hofseth, J.L.; Pittman, D.L.; Wyatt, M.D.; Windust, A.; Nagarkatti, M.; Nagarkatti, P.; Hofseth, L.J. Panaxynol, a Bioactive Component of American Ginseng, Targets Macrophages and Suppresses Colitis in Mice. Preprints2018, 2018030146. https://doi.org/10.20944/preprints201803.0146.v1
Chaparala, A., Poudyal, D., Witalison, E.E., Tashkandi, H., Chumanevich, A.A., Hofseth, J.L., Pittman, D.L., Wyatt, M.D., Windust, A., Nagarkatti, M., Nagarkatti, P., & Hofseth, L.J. (2018). Panaxynol, a Bioactive Component of American Ginseng, Targets Macrophages and Suppresses Colitis in Mice. Preprints. https://doi.org/10.20944/preprints201803.0146.v1
Chaparala, A., Prakash Nagarkatti and Lorne J. Hofseth. 2018 "Panaxynol, a Bioactive Component of American Ginseng, Targets Macrophages and Suppresses Colitis in Mice" Preprints. https://doi.org/10.20944/preprints201803.0146.v1
Ulcerative colitis has a significant impact on the quality of life for the patients, and can substantially increase the risk of colon cancer in patients suffering long-term. Conventional treatments provide only modest relief paired with a high risk of side effects, while complementary and alternative medicines can offer safe and effective options. Over the past decade, we have shown that American ginseng has anti-oxidant and anti-inflammatory properties that can suppress mouse colitis and prevent colitis associated colon cancer. With the goal of isolating a single active compound, we further fractionated the hexane fraction, and found the most abundant molecule in this fraction was the polyacetylene, Panaxynol. After isolating and characterizing Panaxynol, we tested the efficacy of Panaxynol in the treatment and prevention of colitis in mice and studied the mechanism of action. We demonstrate here that Panaxynol effectively treats colitis in a Dextran Sulfate Sodium mouse model by targeting macrophages for DNA damage and apoptosis. Positive outcomes from this study could take American ginseng one-step further towards becoming a conventional drug for the treatment of colitis, and possibility exploring other autoimmune diseases associated with macrophage dysfunction.
Inflammatory Bowel Diseases; ulcerative colitis; American ginseng; Panaxynol; macrophages
Biology and Life Sciences, Immunology and Microbiology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.